10.1371/journal.pone.0108052.t001
Carolin Reischauer
Carolin
Reischauer
Johannes Malte Froehlich
Johannes
Malte Froehlich
Miklos Pless
Miklos
Pless
Christoph Andreas Binkert
Christoph
Andreas Binkert
Dow-Mu Koh
Dow-Mu
Koh
Andreas Gutzeit
Andreas
Gutzeit
Specific therapy, length of progression-free interval, and lesion cross section size on CT before and after treatment for each patient.
Public Library of Science
2014
Cantonal Research Ethics Committee
monitoring treatment response
tumor size
voxel
treatment response
Feasibility Study ObjectiveThe aim
fdm
chemotherapy
percentage
adc
ct
treatment response.ResultsRepeated measures ANOVA
2014-10-07 03:17:45
Dataset
https://plos.figshare.com/articles/dataset/_Specific_therapy_length_of_progression_free_interval_and_lesion_cross_section_size_on_CT_before_and_after_treatment_for_each_patient_/1196740
<p>* The patient deceased prior to tumor progression due to causes unrelated to lung cancer.</p><p>Specific therapy, length of progression-free interval, and lesion cross section size on CT before and after treatment for each patient.</p>